Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · IEX Real-Time Price · USD
1.180
+0.010 (0.85%)
At close: Mar 28, 2024, 4:00 PM
1.161
-0.019 (-1.61%)
After-hours: Mar 28, 2024, 7:14 PM EDT

Gossamer Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019201820172016
Net Income
-179.82-229.38-234-243.36-180.31-146.97-6.77-0.08
Depreciation & Amortization
4.394.435.174.273.090.300
Share-Based Compensation
28.5242.5532.0138.7520.8230.950.030
Other Operating Activities
-12.24-4.647.9423.9811.5764.680.990.1
Operating Cash Flow
-159.16-187.03-188.89-176.36-144.83-51.04-5.750.02
Capital Expenditures
0-0.41-1.55-1.5-2.97-3.4900
Acquisitions
0-0.07-0.08-23.38-3.6-17.7200
Change in Investments
-110.97-0.56-115.81240.23-140.58-123.500
Investing Cash Flow
-110.97-1.04-117.43215.34-147.14-144.7100
Share Issuance / Repurchase
201.77122.93.33118.94293.36000
Debt Issued / Paid
-11.61-5.810193.628.22-0.0460.04
Other Financing Activities
-----300.9--
Financing Cash Flow
190.15117.093.33312.54321.58300.8660.04
Exchange Rate Effect
0.11-0.52-0.170.010.07000
Net Cash Flow
-79.86-71.49-303.15351.5329.67105.10.260
Free Cash Flow
-159.16-187.44-190.44-177.86-147.8-54.53-5.750.02
Free Cash Flow Per Share
-1.04-2.22-2.54-2.60-2.70-8.38-0.630.00
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).